Breaking News Instant updates and real-time market news.

MYL

Mylan

$41.65

-0.2 (-0.48%)

07:02
06/14/18
06/14
07:02
06/14/18
07:02

Mylan's stock may pull back through Q2, says RBC Capital

RBC Capital analyst Randall Stanicky kept his $42 price target and Sector Perform rating on Mylan following yesterday's FDA delay of generic Advair due to "minor deficiencies". The analyst notes that the company may be faced with worse than expressed business pressure and is also concerned that the Street may have over-modeled the Advair contribution, warning that the stock price may pull back through Q2. Stanicky says investors should await a better entry point opportunity on Mylan.

  • 13

    Nov

MYL Mylan
$41.65

-0.2 (-0.48%)

06/05/18
MZHO
06/05/18
NO CHANGE
Target $51
MZHO
Buy
Amgen estimates could drop 2% on Mylan approval, says Mizuho
The consensus 2018 earnings estimates for Amgen (AMGN) could move 2%, or 25c, after Mylan (MYL) won FDA approval for its biosimilar Neulasta, Mizuho analyst Salim Syed tells investors in a research note. The first channel at risk for Amgen is the 340B channel, which is a federal program that requires drug companies to provide drugs at heavily discounted prices, the analyst contends. Syed keeps a Buy rating on Amgen with a $200 price target.
06/05/18
MSCO
06/05/18
NO CHANGE
Target $50
MSCO
Overweight
Neulasta biosimilar could 'reignite' Mylan momentum, says Morgan Stanley
Morgan Stanley analyst David Risinger said FDA approval of Fulphila, Mylan's (MYL) biosimilar to Amgen's (AMGN) Neulasta, should be a "substantial and durable" profit opportunity and could "reignite" Mylan's upward momentum. He notes that Mylan anticipates launching Fulphila in the coming weeks and that the FDA biosimilar user fee act action date for Coherus' (CHRS) Neulasta biosimilar is November 3. Risinger has an Overweight rating and $50 price target on Mylan shares.
06/13/18
BMOC
06/13/18
NO CHANGE
Target $50
BMOC
Outperform
Mylan to have only a 'minor' delay to generic Advair approval, says BMO Capital
BMO Capital analyst Gary Nachman kept his Outperform rating and $50 price target on Mylan after today's post-market close disclosure by the FDA that the company's generic Advair had minor deficiencies. The analyst says that while this is not an "ideal scenario for this much-anticipated catalyst", he confirmed with the management that the FDA used the term "minor" in its letter. Nachman maintains that Mylan is still "very close" to generic Advair, adding that "there will only be a relatively minor delay to ultimate approval".
06/14/18
MZHO
06/14/18
NO CHANGE
Target $51
MZHO
Buy
Mylan to recover from 'modest' generic Advair delay, says Mizuho
Mizuho analyst Irina Koffler says Mylan's "modest" delay for generic Advair approval is unsurprising and unlikely to impact the company's 2018 guidance. She expects the stock to recover and reiterates a Buy rating on the name with a $51 price target.

TODAY'S FREE FLY STORIES

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$278.60

0.71 (0.26%)

14:09
02/20/19
02/20
14:09
02/20/19
14:09
General news
'Almost all' Fed members wanted to announce plan to stop reducing assets »

Minutes from the last…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$278.60

0.71 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$278.27

0.38 (0.14%)

14:06
02/20/19
02/20
14:06
02/20/19
14:06
General news
Fed saw 'variety of considerations' for 'patient approach to monetary policy' »

Minutes from the last…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$278.27

0.38 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$278.32

0.43 (0.15%)

14:05
02/20/19
02/20
14:05
02/20/19
14:05
General news
Fed to continue monitoring economic developments for outlook implications »

Minutes from the last…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$278.32

0.43 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$278.34

0.45 (0.16%)

14:02
02/20/19
02/20
14:02
02/20/19
14:02
General news
Fed sees 'sustained expansion of economic activity' as most likely outcome »

Minutes from the last…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$278.34

0.45 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDP

Fresh Del Monte

$29.97

0.7 (2.39%)

14:00
02/20/19
02/20
14:00
02/20/19
14:00
Hot Stocks
Breaking Hot Stocks news story on Fresh Del Monte »

Fresh Del Monte trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHC

Bausch Health

$23.13

-2.04 (-8.10%)

14:00
02/20/19
02/20
14:00
02/20/19
14:00
Options
Dip buyer in Bausch Health Companies »

Dip buyer in Bausch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 12

    Mar

  • 12

    Mar

VLKAY

Volkswagen

$0.00

(0.00%)

, AUDVF

Audi AG

$0.00

(0.00%)

13:59
02/20/19
02/20
13:59
02/20/19
13:59
Periodicals
Audi plans to cut 10% of management positions, Reuters reports »

Audi (AUDVF),…

VLKAY

Volkswagen

$0.00

(0.00%)

AUDVF

Audi AG

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTD

Trade Desk

$146.31

-15.45 (-9.55%)

13:58
02/20/19
02/20
13:58
02/20/19
13:58
On The Fly
Trade Desk slides after analyst cuts rating ahead of quarterly results »

Shares of Trade Desk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 06

    Mar

  • 06

    Mar

UA

Under Armour

$19.15

-0.23 (-1.19%)

13:55
02/20/19
02/20
13:55
02/20/19
13:55
Options
Under Armour put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 06

    Mar

PM

Philip Morris

$85.42

2 (2.40%)

13:50
02/20/19
02/20
13:50
02/20/19
13:50
Earnings
Philip Morris repeats Q1 reported diluted EPS view of $1.00, consensus $1.01 »

As communicated on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PM

Philip Morris

$85.42

2 (2.40%)

13:49
02/20/19
02/20
13:49
02/20/19
13:49
Earnings
Philip Morris reaffirms FY19 reported diluted EPS guidance of at least $5.37 »

Philip Morris…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:45
02/20/19
02/20
13:45
02/20/19
13:45
General news
Fed's Kaplan said a weaker business outlook is the reason for caution on rates »

Fed's Kaplan said a…

13:45
02/20/19
02/20
13:45
02/20/19
13:45
General news
Breaking General news story  »

FOMC Minutes to be…

MDR

McDermott

$7.80

0.44 (5.98%)

13:40
02/20/19
02/20
13:40
02/20/19
13:40
Options
Bullish option play in McDermott as shares rally ahead of earnings »

Bullish option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 04

    Mar

  • 05

    Mar

  • 12

    Mar

  • 17

    Mar

  • 18

    Mar

  • 02

    May

STAG

STAG Industrial

$28.24

-0.59 (-2.05%)

13:34
02/20/19
02/20
13:34
02/20/19
13:34
Recommendations
STAG Industrial analyst commentary  »

STAG Industrial price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,118.00

-0.16 (-0.01%)

, GOOGL

Alphabet Class A

$1,125.12

-1.31 (-0.12%)

13:28
02/20/19
02/20
13:28
02/20/19
13:28
Periodicals
Epic Games stops 'Fortnite' pre-roll ads on YouTube due to predators, Verge says »

Epic Games is no longer…

GOOG

Alphabet

$1,118.00

-0.16 (-0.01%)

GOOGL

Alphabet Class A

$1,125.12

-1.31 (-0.12%)

TCEHY

Tencent

$0.00

(0.00%)

DIS

Disney

$113.63

0.11 (0.10%)

KKR

KKR

$23.52

-0.2 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 27

    Feb

  • 03

    Mar

  • 07

    Mar

  • 18

    Mar

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$278.00

0.11 (0.04%)

13:28
02/20/19
02/20
13:28
02/20/19
13:28
Periodicals
Barr could announce end of Mueller investigation next week, CNN reports »

Attorney General Bill…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$278.00

0.11 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMI

Owens & Minor

$6.40

-1.54 (-19.40%)

13:24
02/20/19
02/20
13:24
02/20/19
13:24
Periodicals
Owens & Minor working with banks to explore sale, Reuters reports »

Owens & Minor is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

OMI

Owens & Minor

$6.41

-1.53 (-19.27%)

13:20
02/20/19
02/20
13:20
02/20/19
13:20
Hot Stocks
Breaking Hot Stocks news story on Owens & Minor »

Owens & Minor trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

OMI

Owens & Minor

$6.41

-1.53 (-19.27%)

13:18
02/20/19
02/20
13:18
02/20/19
13:18
Hot Stocks
Breaking Hot Stocks news story on Owens & Minor »

Owens & Minor halted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

GOLD

Barrick Gold

$13.98

0.43 (3.17%)

13:17
02/20/19
02/20
13:17
02/20/19
13:17
Hot Stocks
Barrick Gold confirms commitment to Chile as it reviews LATAM strategy »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMI

Owens & Minor

$6.41

-1.53 (-19.27%)

13:17
02/20/19
02/20
13:17
02/20/19
13:17
Periodicals
Breaking Periodicals news story on Owens & Minor »

Owens & Minor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
02/20/19
02/20
13:17
02/20/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$161.80

-0.49 (-0.30%)

, GOOG

Alphabet

$1,114.63

-3.53 (-0.32%)

13:16
02/20/19
02/20
13:16
02/20/19
13:16
On The Fly
#SocialStocks: YouTube updates penalty system, Twitter developing Snapchat-like camera »

Welcome to…

FB

Facebook

$161.80

-0.49 (-0.30%)

GOOG

Alphabet

$1,114.63

-3.53 (-0.32%)

GOOGL

Alphabet Class A

$1,121.14

-5.29 (-0.47%)

TWTR

Twitter

$31.37

-0.27 (-0.85%)

SNAP

Snap

$9.17

-0.11 (-1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 03

    Mar

  • 18

    Mar

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
02/20/19
02/20
13:16
02/20/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.